FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Jul. 31, 2020

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

The Company's assets and liabilities that were measured at fair value on a recurring basis are set forth by level within the fair value hierarchy in the following tables (in thousands):

	As of July 31, 2020
	Quoted Prices in Active Markets for Identical Assets (Level 1)	Significant Other Observable Inputs (Level 2)	Significant Unobservable Inputs (Level 3)	Total
Assets:
Deferred compensation plan:
Corporate-owned life insurance	$—	$176,921	$—	$176,921
Money market funds	1,011	—	—	1,011
Total assets	$1,011	$176,921	$—	$177,932
Liabilities:
Contingent consideration	$—	$—	$18,015	$18,015

	As of October 31, 2019
	Quoted Prices in Active Markets for Identical Assets (Level 1)	Significant Other Observable Inputs (Level 2)	Significant Unobservable Inputs (Level 3)	Total
Assets:
Deferred compensation plan:
Corporate-owned life insurance	$—	$151,871	$—	$151,871
Money market funds	20	—	—	20
Total assets	$20	$151,871	$—	$151,891
Liabilities:
Contingent consideration	$—	$—	$18,326	$18,326

Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]

The Level 3 inputs used to derive the estimated fair value of the Company's contingent consideration liability as of July 31, 2020 were as follows:

	Fiscal 2017 Acquisition
Compound annual revenue growth rate range	(3	%)	-	10%
Weighted average discount rate	3.3%

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

Changes in the Company’s contingent consideration liability measured at fair value on a recurring basis using unobservable inputs (Level 3) for the nine months ended July 31, 2020 are as follows (in thousands):

	Liabilities
Balance as of October 31, 2019	$18,326
Increase in accrued contingent consideration, net	189
Payment of contingent consideration	(500)
Balance as of July 31, 2020	$18,015